175 results
Page 4 of 9
8-K
EX-1.1
xsq33m6vf ikjk6f7
8 Oct 21
Agile Therapeutics Appoints Josephine Torrente to its Board of Directors
5:23pm
8-K
EX-99.2
aj3r hp5k
8 Oct 21
Agile Therapeutics Appoints Josephine Torrente to its Board of Directors
5:23pm
8-K
EX-99.3
gc0 nmbe29
8 Oct 21
Agile Therapeutics Appoints Josephine Torrente to its Board of Directors
5:23pm
8-K
EX-99.1
s2lgrf
8 Oct 21
Agile Therapeutics Appoints Josephine Torrente to its Board of Directors
5:23pm
424B5
xqp9vpi
8 Oct 21
Prospectus supplement for primary offering
5:21pm
424B5
k6ibprfraf9sjc02e
7 Oct 21
Prospectus supplement for primary offering
5:24pm
8-K
EX-99.1
x2prs2gr
4 Oct 21
Agile Therapeutics Announces Addition of Twirla® to a Preferred Drug Position on Medi-Cal Formulary
4:30pm
8-K
EX-99.1
mgppslb4f5 bgkxj589y
26 Jul 21
Agile Therapeutics Reports Second Quarter 2021 Financial Results
4:10pm
8-K
EX-99.1
l8l5kacdsj4jrzr
4 May 21
Agile Therapeutics Reports First Quarter 2021 Financial Results
4:10pm
424B5
jiczu9ciz73i
18 Mar 21
Prospectus supplement for primary offering
5:01pm
8-K
EX-99.1
wq6eevmdv5jouatjmog
1 Mar 21
Results of Operations and Financial Condition
4:10pm
8-K
EX-99.1
ibn5kleh
14 Jan 21
Results of Operations and Financial Condition
8:30am
8-K
9zrcpckd76xru oj
14 Jan 21
Results of Operations and Financial Condition
8:30am
8-K
EX-99.1
fe6nu 8u1
7 Dec 20
Other Events
4:30pm